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Abstract. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
is considered a housekeeping protein that is present in virtually all 
organisms, where it performs metabolic functions essential for 
survival. GAPDH plays an essential role in the process of energy 
production, and is also involved in numerous biological processes. 
GAPDH belongs to a subset of proteins called moonlighting 
proteins, in which different functions are associated with a single 
polypeptide chain. The multifunctionality of GAPDH has been 
described in pathogenic and probiotic microorganisms, in 
mammals and in plants. In this review, we summarize the 
moonlighting role of GAPDH in bacteria.  
 
 
1. Moonlighting proteins 
 
 There are different mechanisms by which a gene may encode multiple 
functions, but there are also mechanisms that determine the ability of a given 
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protein to perform more than one function. One subset of multifunctional 
proteins are called moonlighting proteins, in which the different functions are 
associated with a single polypeptide chain. A general feature of moonlighting 
proteins is that their different functions are unrelated and independent. 
Consequently, the inactivation of one of the functions does not usually affect 
the other functions and vice-versa [1]. It has been hypothesized that many of 
these proteins initially had just one role, but acquired additional functions 
during evolution. Proteins in which the different functions result from gene 
fusion, homologous protein families, splice variants or enzymes with 
promiscuous activity are not considered moonlighting proteins, nor are 
proteins that exhibit the same function in different cell types or subcellular 
localizations [2,3,4].   
 The first examples of moonlighting proteins were described in the early 
1980s, when it was discovered that certain structural proteins in the lens of 
vertebrates were well-known metabolic enzymes such as argininosuccinate 
lyase [5], lactate dehydrogenase [6] or the glycolytic enzyme enolase [7]. At 
present, the concept of moonlighting protein is not restricted to enzymes, but 
also applies to other proteins such as receptors, membrane channels, 
chaperones and ribosomal proteins. 
 Different mechanisms have been proposed to explain how a 
moonlighting protein can exert different functions. Thus, the function of the 
protein may vary according to its subcellular localization, cell type, 
oligomeric state, interaction with other proteins or macromolecules, cell 
concentration of a ligand, substrate, cofactor or product. In these proteins, the 
binding of a metabolite, interaction with another protein or association into a 
multiprotein complex may induce a change in function. In most cases, these 
strategies are not mutually exclusive and a combination of them may be 
involved. In general, moonlighting proteins use different exposition surfaces 
for each function. In this context, the resolution of the three dimensional 
structure of multifunctional proteins is of great importance since, in many 
cases, it provides key information about the molecular mechanism associated 
with each of the functions [4].  
 An example of a moonlighting protein with a known switching 
mechanism between functions is PutA of Escherichia coli or Salmonella 
typhimurium. In the absence of proline, this protein remains in the cytoplasm 
where it acts as a transcriptional repressor through its interaction with a 
specific DNA sequence in the promoter of the put operon. However, binding 
of proline induces a conformational change that leads PutA protein to 
associate with the cell membrane where, by means of its proline 
dehydrogenase and pyrroline–5-carboxylate dehydrogenase activities, it 
catalyses the degradation of proline [8].   
Moonlighting GAPDH in bacteria  167 
 Until now, many of the functions of proteins could be inferred from 
known functions of homologous proteins. However, the existence of 
moonlighting proteins complicates this interpretation. Similarly, 
multifunctionality can hinder the analysis of results obtained from proteomic 
studies, since the same protein can have different expression patterns or 
multiple non-related interaction partners. Nevertheless, large-scale proteomic 
approaches can be very useful in identifying moonlighting proteins [4]. Thus, 
identification of a protein in a non-expected cell type or as a part of a new 
multiprotein complex may suggest a new function for it. For example, using a 
proteomic microarray-based approach, new DNA-binding activity was 
identified for the yeast mitochondrial enzyme Arg5,6(N-acetyl-gamma-
glutamyl phosphate reductase/ acetylglutamate kinase) involved in the 
synthesis of ornithine [9]. In the immediate future, proteomic studies of this 
type, which use massive screening methods, are seen as tools of great 
potential for identifying new moonlighting proteins.  
 The existence of multifunctional proteins benefits the organism. It 
reduces the number of proteins to synthesize, and therefore the amount of 
DNA to replicate. In many cases, the combination of functions provides a 
mechanism to coordinate diverse cellular processes, such as metabolic and 
signalling pathways, which allows the cell to respond to changes in the 
environment.  
 
2. Bacterial secreted moonlighting proteins and virulence 
 
  An increasing number of reports show that certain pathogenic 
microorganisms (bacteria, fungi, and parasites) display typically considered 
cytoplasmic proteins on the cell surface, where they exert functions related 
with virulence. These are highly conserved housekeeping proteins with basic 
metabolic functions essential for survival that fit into the category of 
moonlighting proteins. Considering bacterial moonlighting proteins in the 
context of bacteria-host interactions, besides their basic metabolic function, 
when secreted these proteins play a role in host adhesion and/or virulence. 
Once in the extracellular medium, these proteins have been shown to interact 
with host components, or interact directly with the host cells to elicit signal 
transduction events, and in this way enable pathogens to colonize and 
modulate the host immune response. Examples of these moonlighting 
proteins are glycolytic enzymes such as glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), enolase, fructose-bisphosphate aldolase or 
pyruvate kinase, other metabolic enzymes such as malic enzyme or succinyl-
CoA synthase subunits, chaperones like DnaK or GroEL, and the elongation 
factor EF-Tu [10,11]. 
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 These cytoplasmic moonlighting proteins lack any typical secretion 
signal and the mechanism responsible for their secretion remains in many 
cases unknown. Although several studies point to cell lysis as the mechanism 
involved in the release of these non-classically secreted proteins into the 
extracellular medium [12], specific secretion processes have been reported 
[13]. For instance, in Mycobacterium tuberculosis and Listeria 
monocytogenes the SecA2-dependent system has been shown to be involved 
in the secretion of some of these cytoplasmic proteins [14,15]. In 
staphylococcus aureus, the export of such proteins depends on the major 
autolysin Atl [16]. 
 
3. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as 
a moonlighting protein 
 
 GAPDH (EC 1.2.1.12) is a constitutively expressed enzyme that plays 
an important role in the glycolytic pathway, due to its catalytic activity in the 
synthesis of 1,3-bisphosphoglycerate. This enzyme is considered a 
housekeeping protein that is present in practically all organisms, where it 
performs metabolic functions essential for survival. The enzyme is even 
expressed in organisms that lack the tricarboxylic acid cycle, which provides 
essential metabolic activity for anaerobic or microaerophilic growth. 
Although GAPDH plays an essential role in the process of energy production, 
it cannot be considered only as a classic glycolytic protein. Several studies 
described GAPDH as a multifunctional protein involved in numerous 
biological processes in pathogens [10], probiotics [17,18], mammals [19,20] 
and plants [21]. Indeed, GAPDH can be considered a model of a 
moonlighting protein that displays a wide variety of cellular functions, due to 
their ability to form complex interactions. The multifunctionality of GAPDH 
has been extensively documented in human cells, where it was shown to be 
involved in numerous cellular processes, such as transcriptional and post-
transcriptional gene regulation, chromatin structure, intracellular trafficking, 
DNA replication and DNA repair [19,20,22]. Each novel function requires 
GAPDH association into specific protein complexes and may involve 
different regions of the protein structure. The different moonlighting 
functions of GAPDH may also depend on specific post-translational 
modifications, which can define its oligomeric state, subcellular localization 
and/or different binding partners [19,20,23]. In fact, GAPDH was shown to 
be the target of several covalent modifications such as S-glutathionylation,  
S-nitrosylation, phosphorylation, acetylation and ADP-ribosylation among 
others. These changes give rise to various forms of the protein, which differ 
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in their isoelectric point, and therefore can be separated by two-dimensional 
gel electrophoresis. Most of these modifications are associated with oxidative 
stress responses and may have important physiological consequences [24]. 
 
4. Extracellular GAPDH in Gram-positive pathogens  
 
 As stated above, GAPDH is one of the proteins secreted and exposed on 
the bacterial surface, which enables pathogens to colonize and manipulate 
host cells [10]. 
 The first description of the location of GAPDH on the surface of a 
pathogen was in Streptococcus pyogenes, a Gram-positive bacterium that 
causes pharyngitis and skin infections [25-27]. The protein located on the 
bacterial surface is enzymatically active and able to bind several human 
proteins such as fibronectin, lysozyme, laminin, cytoskeletal proteins (myosin 
and actin) [26] and proteins from the human fibrinolytic system (fibrinogen) 
[26,28,29]. In addition, in pharyngeal cells the membrane protein 
uPAR/CD87 (urokinase plasminogen activator receptor) was identified as a 
receptor for S. pyogenes extracellular GAPDH [30]. It has been shown that 
interaction of group A Streptococci with human plasminogen through surface 
exposed GAPDH improves adhesion of these pathogens to the pharyngeal 
cells [29]. Plasminogen is the zymogen form of plasmin, an enzyme with 
serine-protease activity that is abundant in human plasma and extracellular 
fluids, and plays a fundamental role in the dissolution of fibrin clots, the 
extracellular matrix and other key proteins involved in immunity and tissue 
repair [31]. In this context, extracellular GAPDH either in the surface of the 
pathogen or secreted near the host cell promotes activation of plasminogen to 
plasmin, which can degrade extracellular matrix proteins and facilitate 
bacterial migration. GAPDH has also been found on the surface of other 
Streptococci, such as the swine pathogen Streptococcus suis serotype 2 and 
Streptococcus pneumoniae [32-35]. In these pathogens, GAPDH also acts as 
a plasminogen receptor. The involvement of GAPDH in the infection 
mechanism by means of its ability to interact with plasminogen is not specific 
for Streptococci isolates, but has also been reported for other Gram-positive 
pathogens such as Bacillus anthracis. In this pathogen, GAPDH has been 
detected both in the secretome and at the spore surface [36]. In Mycoplasma 
pneumoniae, cell surface exposed GAPDH mediates interactions with the 
extracellular matrix proteins of the human host and contributes to the 
colonization of the respiratory tract [37]. 
 Other studies report the ability of extracellular Streptococci GAPDH to 
interact with the C5a component of the complement system, which promotes 
its degradation, in coordination with the bacterial surface protease (SCPA). 
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This strategy allows the pathogen to escape from detection by the host 
immune system [38]. In Group B Streptococci, comprised of human 
commensal bacteria with the capacity to cause life-threatening meningitis and 
septicaemia in newborns, GAPDH is exported outside the cell [39]. In this 
extracellular location, GAPDH can induce activation of polyclonal B cells 
and secretion of interleukin IL-10. The ability of microbial components to 
induce the activation of polyclonal B cells of the infected host is an immune 
evasion mechanism employed by pathogens to suppress specific immune 
responses. IL-10 has anti-inflammatory effects, and therefore its stimulation 
by GAPDH may decrease the immune response and facilitate colonization by 
the pathogen [40].  
 Soluble GAPDH was identified as the main protein secreted into the 
extracellular medium by Streptococcus gordonii FSS2, which produces 
endocarditis. In this pathogen, secretion of GAPDH is regulated by pH. This 
protein remains associated with the cell surface at pH 6.5, whereas a shift to 
pH 7.5 causes its secretion to the medium [41]. New functions of 
extracellular GAPDH have been reported in other Gram-positive pathogens. 
In Listeria monocytogenes, cell wall-associated GAPDH was shown to 
catalyse the ADP-ribosylation of Rab5a [42], a protein that localizes to early 
endosomes. ADP-ribosylation of Rab5a blocked the Rab5a-exchange factor 
(Vps9) and impaired maturation to late endosomes [43]. In Streptococcus 
oralis, extracellular GAPDH can bind the major fimbriae of the Gram-
negative pathogen Porphyromonas gingivalis. This interaction is important 
for colonization of the oral cavity by this pathogen [44]. 
 Moreover, the ability of antibodies against bacterial GAPDH to mediate 
opsonophagocytosis and to provide protection against bacterial infection by 
Gram-positive pathogens such as Streptococcus pyogenes [30,45], 
Streptococcus agalactiae [40] or Bacillus anthracis [36] points to GAPDH as a 
potential vaccine target. The proposed functions in host interaction of 
extracellular GAPDH of Gram-positive pathogens are summarized in Table 1. 
 
5. Extracellular GAPDH in Gram-negative pathogens   
 
 As stated above, the first description of GAPDH on the surface of 
Gram-positive pathogens was published in 1992 [25,26]. However, reports 
describing the extracellular localization of GAPDH in Gram-negative 
pathogens and the involvement of this protein in the interaction with the host 
appeared more than 10 years later. Our group has contributed to this field. 
We showed that GAPDH is localized on the surface of enteropathogenic 
(EPEC) or enterohemorrhagic (EHEC) Escherichia coli strains and that this 
protein is also secreted into the medium in a soluble and active form [46]. 
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Although secretion of GAPDH is regulated by environmental pH in other 
bacteria [41,47], this factor does not affect GAPDH secretion in EHEC and 
EPEC strains. In these pathogens, secretion depends on the external medium 
and temperature. The protein is secreted at 37ºC by cells grown in LB or in 
eukaryotic culture media such as DMEM or Ham’s F12, but not in glucose 
minimal medium [46]. Western blot and ELISA assays have revealed the 
capacity of this protein to interact with the human proteins fibrinogen and 
plasminogen, as well as its association with Caco-2 cells upon infection [46]. 
Pathogens need to attach to host components as the first step in the 
establishment of infection. As mentioned above, these interactions with 
human proteins confer GAPDH a function in the degradation of extracellular 
matrix proteins that, in the case of enteropathogens, would facilitate their 
migration through the intestinal mucosa. Another aspect of GAPDH function 
in the interaction with the intestinal mucosa is linked to post-translational 
modifications, such as ADP-ribosylation. This is a reversible, covalent 
modification in which the ADP-ribose moiety of NAD
+
 is enzymatically 
transferred to a specific amino acid of the target protein. We have shown that 
E. coli GADPH catalyses its own modification and that this modification 
affects Cys149 at the active site. ADP-ribosylation assays have shown that 
the E. coli enzyme is modified by NAD
+
 both in the cytosol and in the 
extracellular medium, and that nitric oxide stimulates the NAD
+
-dependent 
post-translational modification of GAPDH [48]. ADP-ribosylation of 
extracellular GAPDH may play an important role in bacteria-host interaction, 
as proposed for other pathogens. The secreted protein may protect bacteria 
against the oxidative host response during infection and/or it may be involved 
in signal transduction events in the host [26,48]. 
 Studies performed in our group have provided genetic and biochemical 
evidence that at least two different secretion pathways mediate GAPDH 
secretion in EPEC, depending on the growth conditions. In cells grown in 
DMEM, GAPDH secretion depends on T3SS, whereas in cells grown in LB, 
conditions that do not induce the expression of T3SS proteins, GAPDH is 
secreted by a T3SS-independent system that has not yet been identified [49]. 
EPEC and EHEC are members of a related family that intimately attach to the 
intestinal epithelial cells and induce characteristic attaching and effacing 
(A/E) lesions on the host cells, causing diarrhoea. In EPEC, the ability to 
induce A/E effects is encoded in a 41-gene pathogenicity island, called the 
locus of enterocyte effacement (LEE). The T3SS components are encoded in 
this locus together with transcriptional regulators, chaperones and effector 
proteins. EPEC can secrete and translocate multiple effector proteins to the 
infected cells through the T3SS. The secretion process is dependent 
frequently on a bacterial chaperone that is not secreted. One chaperone that 
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displayed broad substrate specificity and plays a central role in recruiting 
multiple type III effectors to the T3SS is CesT. This soluble, small protein 
interacts with type III ATPase EscN and promotes the recruitment of cognate 
effectors to the T3SS apparatus for efficient secretion [50]. Our studies 
showed that secretion of GAPDH in DMEM is abolished in a mutant 
defective in the type III ATPase EscN, but restored upon complementation 
with the escN gene. It is well-known that escN mutations abolish secretion of 
both translocator and effector proteins through the T3SS apparatus. In cells 
that are defective in SepD protein, secretion of GAPDH is increased, which is 
in accordance with previous results for other T3SS effectors. Direct binding 
of CesT with GAPDH was shown by means of different methodologies such 
as pull-down experiments, overlay immunoblotting and bilayer 
interferometry. We evidenced that this interaction is strong and slow 
dissociating. Modelling of the N-terminal sequence of E. coli GAPDH 
revealed that this protein displays in this region the structural determinants of 
the CesT targets. We proposed that during the synthesis of GAPDH in 
ribosomes, interaction of its nascent N-terminal sequence with CesT may 
stabilize a population of GAPDH molecules in a secretion competent-state 
and target them to the T3SS secretion apparatus.  
 In addition to E. coli, there are descriptions of GAPDH on the surface of 
other gram-negative pathogens, as in Neisseria meningitidis [51], Brucella 
abortus [52] and Edwardsiella tarda [53]. Neisseria meningitidis has two 
genes (gapA1 and gapA2) encoding GAPDH. From them, gapA1 has been 
reported to be up-regulated upon bacterial contact with human epithelial 
cells. Constitutive expression of gapA1 has been seen among diverse isolates 
of Neisseria species, whereas the GapA1 protein can only be detected on the 
surface of capsule-deficient strains. GapA1 is not necessary for Neisseria 
growth in vitro, but deficiency in GapA1 significantly reduces adhesion of 
the pathogen to human epithelial and endothelial cells through a capsule-
independent mechanism. From these results, the authors suggested a role of 
GapA1 in the pathogenesis of meningococcal infection [51]. In Brucella abortus, 
recombinant GAPDH protein was shown to have immunoreactive properties 
and induce a protective T-cell mediated immune response in mice and natural 
hosts as well as in acute brucellosis patients [54]. The Brucella recombinant 
GAPDH protein was recognized by IgG antibodies from naturally infected 
sheep and cattle, which supports its potential use as a vaccine. In fact, partial 
protection against Brucella infection was achieved in mice upon 
immunization with gap and IL-12 genes [52]. The use of recombinant 
GAPDH as a protective antigen in vaccination processes has also been 
explored in Edwardsiella tarda, a Gram-negative pathogen which causes 
systemic infection in turbot. The increasing frequency of edwardsiellosis in 
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fish farming has stressed the need to develop prevention and control 
strategies. A vaccine based on E. tarda recombinant GAPDH has been 
proven to significantly protect zebrafish not only against E. tarda, but also 
against Aeromonas hydrophila, Vibrio anguillarum, Vibrio alginolyticus and 
Vibrio harvei, thus showing its potential as a vaccine candidate against 
polymicrobial infections in the aquaculture industry [55]. The proposed 
functions in host interaction of extracellular GAPDH of Gram-negative 
pathogens are also summarized in Table 1. 
 
6. Extracellular GAPDH in probiotics 
 
 Certain extracellular activities are advantageous in the colonization of 
the intestinal mucosa and may in fact be a mechanism of competition 
between commensal or probiotic bacteria versus pathogens. In this context, 
certain housekeeping proteins secreted by pathogens, initially related to their 
pathogenesis mechanisms, have been identified in recent years in the 
secretome of probiotic strains. Probiotics are a group of non-pathogenic 
intestinal microorganisms that, when administered to humans, produce 
positive effects on the microbiota balance and increase gastrointestinal 
homeostasis. They are utilized as dietary supplements or as pharmaceutical 
products in the treatment of intestinal alterations and diseases. Some 
probiotic strains reduce colonization by pathogens through direct competition 
for adhesion sites, the production of antimicrobial agents, or modulation of 
the host’s acquired immune response. Furthermore, they have a beneficial 
influence upon the epithelial cells, thereby regulating their development and 
function. By virtue of their extracellular localization, proteins secreted by 
probiotic strains may be responsible for some of these probiotic traits [56,57]. 
In order to identify proteins related with probiotic effects or the adaptation of 
bacteria to changing environmental conditions, several studies have been 
carried out to characterize the secretome of Gram-positive probiotics [58-60]. 
Among the housekeeping proteins secreted by Gram-positive probiotics are 
EF-Tu, enolase, GroEL chaperone, or GAPDH. 
 Regarding GAPDH, several reports describe GAPDH secretion by some 
Gram-positive probiotic Lactobacillus species [56,60,61], and by the            
Gram-negative probiotic Escherichia coli Nissle 1917 [49]. In Lactobacillus 
plantarum, export of GAPDH to the bacterial cell surface was shown to be 
closely related to plasma membrane permeability [62]. In E. coli Nissle 1917, 
GAPDH was found in the proteome of outer-membrane vesicles isolated 
from LB cultures [63]. L. plantarum extracellular GAPDH can bind mucin 
[17]. The adhesion mechanism can be partly attributed to GAPDH binding          
to human ABO-type blood group antigens expressed on human colonic mucin  
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Table 1. Bacterial extracellular GAPDH and the proposed function in bacteria-host 
interaction. 
 
Bacteria Host target  Functions References 
Gram-positive  
Streptococcus 
pyogenes 
Fibronectin, 
lysozyme, laminin, 
myosin, actin, 
fibrinogen, 
uPAR/CD87 
Adhesion and 
degradation of 
extracellular matrix 
proteins. Bacterial 
migration 
[26,28,29,30] 
C5a component of 
the complement 
system 
C5a degradation. 
Evasion of the host 
immune system 
[38] 
Streptococcus suis  
serotype 2 
Plasminogen Degradation of 
extracellular matrix 
proteins 
[32,34] 
Streptococcus  
pneumoniae 
Plasminogen Degradation of 
extracellular matrix 
proteins 
[33,35] 
Streptococci  group B  Induction of polyclonal 
B cells and secretion of 
IL-10. 
Decrease of immune 
response. 
Contribution to the 
colonization process 
[39,40] 
Bacillus antracis  Plasminogen Degradation of 
extracellular matrix 
proteins 
[36] 
Mycoplasma 
pneumoniae 
Fibrinogen. Interaction with 
extracellular matrix. 
Colonization of the 
respiratory track 
[37] 
Lysteria 
monocytogenes  
Rybosylation of 
Rab5a 
Impaired maturation 
to late endosomes 
[43] 
Gram-negative  
Escherichia coli 
(EHEC and EPEC) 
Fibrinogen, 
plasminogen  
Adhesion  and 
degradation of 
extracellular matrix 
[46,48] 
Neisseria meningitidis  Adhesion to epithelial 
and endothelial cells 
[51] 
Brucella abortus   Induction of protective 
T-cell mediated 
immune response 
[52,54] 
Probiotics  
Lactobacillus 
plantarum 
Mucin Adhesion to the 
intestinal mucosa 
[17,18] 
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[18]. It has been suggested that GAPDH interaction with mucin helps the 
probiotic to colonize the human intestinal mucosa, and provides a mechanism 
for competition with pathogens that also secrete this protein (Table 1). 
Studies performed with 30 lactobacilli isolates from human intestinal samples 
revealed a good correlation between extracellular GAPDH activity and the 
adhesion capacity to human colonic mucin. This fact has led authors to 
propose a new screening method based on extracellular GAPDH enzymatic 
activity to predict highly adhesive lactobacilli without the need to perform 
adhesion tests, which are complex and time-consuming [64]. In a similar 
study, adhesion to mucin was investigated in 43 human lactobacilli (32 
vaginal and 11 intestinal isolates). GAPDH was found among the bacterial 
proteins recovered from mucin binding experiments [65].  
 
7. Moonlighting functions of intracellular GAPDH in bacteria 
 
 Besides the role of secreted GAPDH in virulence or host colonization 
processes, few studies have dealt with new GAPDH intracellular functions 
that are unrelated to glycolysis in bacteria. 
 As stated above, GAPDH export to the bacterial surface is an essential 
step in the pathogenesis of Streptococcus pyogenes. Studies performed with a 
strain expressing a modified GAPDH form that prevents its export to the cell 
surface showed down-regulation of emm1, a gene encoding the cell wall 
protein M, which is one of the main virulence factors of this pathogen [29]. A 
transcriptomic analysis of this mutant, which displays higher GAPDH 
intracellular levels than the wild type strain, revealed down-regulation of 
genes encoding virulence factors as well as genes involved in carbohydrate 
and amino acid metabolism, whereas genes involved in lipid metabolism 
were up-regulated. These results prompted the authors to suggest a new role 
for intracellular GAPDH in the transcriptional control of virulence genes [45] 
(Fig. 1). In E. coli, some studies also suggest that GAPDH could interact with 
DNA and act as a regulator of gene expression. In a study performed by 
Green et al. [66] using the methodology of Dynabeads, GAPDH was 
identified among the proteins that could interact with the promoter of ndh 
gene, which encodes NADH oxidase-2. However, no functional 
characterization of this interaction has been performed so far.  
 To explore new GAPDH functions in E. coli, we carried out protein 
interaction studies. In the area of systems biology, the identification of 
protein-protein interactions within cells is of prime importance to understand 
biological processes at the molecular level. Indeed, most human GAPDH 
functions were identified through the detection of GAPDH as a component of 
protein complexes involved in the cellular processes under study [20]. We 
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investigated new intracellular functions of E. coli GAPDH following a 
proteomic approach, to identify the proteins that interact with GAPDH using 
in vivo formaldehyde cross-linking followed by mass spectrometry-based 
protein identification. This methodology covalently fixes interaction partners 
in living cells, thus allowing identification of even transient interactions or 
weakly binding proteins [67]. Experiments were performed with E. coli cells 
that express GAPDH fused to the V5 epitope to facilitate immunoaffinity 
purification of the protein complexes with anti-V5 beads. Experiments in the 
absence of cross-linking were also performed. From these experiments, 
several proteins were identified to putatively interact with GAPDH. The 
identified proteins include the metabolic enzymes phosphoglycolate 
phosphatase, enolase, tryptophanase, the ATP synthase - and -subunits, 
aldehyde dehydrogenase, pyruvate kinase, transketolase, aconitase, 
anthranilate synthase component II, dihydrolipoyl dehydrogenase,                    
D-tagatose-1-6-bisphosphatase, the ATP binding proteins AraG and RbsA, the 
chaperones DnaK and trigger factor, the periplasm D-ribose binding protein 
(RbsB), the outer membrane protein OmpC, as well as factors involved in 
protein synthesis such as EF-Tu [68]. Four proteins (trigger factor, DnaK, 
phosphoglycolate phosphatase and aldehyde dehydrogenase) also appeared as 
candidates to interact with GAPDH in other large-scale studies performed in 
E. coli following different approaches [69,70] or in databases such as DIP 
(database of interacting proteins) or IntAct. Since proteomic studies aimed at 
identifying protein interactions are intended to assign new functions to a 
given protein, we further characterized GAPDH interaction                                  
with phosphoglycolate phosphatase (Gph). This enzyme is involved in the  
 
 
 
Figure 1. Intracellular functions of GAPDH in bacteria. The experimental evidences 
for function assignment are indicated in gray and the proposed functions in blue.  
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metabolism of 2-phosphoglycolate formed in the DNA repair of                            
3- phosphoglycolate ends generated by bleomycin damage [71]. We showed 
that interaction between Gph and GAPDH increases in cells treated with 
bleomycin, which suggests that GAPDH may be involved in cellular 
processes linked to DNA repair mechanisms. Moreover, since                              
2-phosphoglycolate is also generated in the degradation of the autoinducer-2 
precursor 4,5-dihydroxy-2,3-pentanedione (DPD) [72,73], interaction 
between GAPDH and Gph may suggest that GAPDH participates in quorum 
sensing signalling processes [68] (Fig. 1).  
 
8. Conclusion 
 
GAPDH, a key glycolysis enzyme, is a moonlighting protein 
performing additional functions unrelated with its original metabolic role. 
In bacteria, moonlighting GAPDH functions have been mainly associated 
with its extracellular location. This protein is secreted and exposed on the 
bacterial surface enabling pathogens and probiotics to colonize and/or 
modulate the host immune response. Multifunctionality of intracellular 
GAPDH has been widely studied in humans; however such kind of studies 
is scarce in bacteria. Recent reports on S. pyogenes and E. coli provide 
evidence that bacterial GAPDH may also be involved in intracellular cell 
processes like transcriptional regulation, DNA repair and quorum sensing 
signaling.   
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